Symbols / NOVT Stock $128.88 -2.94% Novanta Inc.

Technology • Scientific & Technical Instruments • United States • NMS
NOVT (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Technology
Industry Scientific & Technical Instruments
CEO Mr. Matthijs Glastra
Exch · Country NMS · United States
Market Cap 4.59B
Enterprise Value 4.66B
Income 53.83M
Sales 980.60M
FCF (ttm) 64.27M
Book/sh 36.84
Cash/sh 10.67
Employees 3,000
Insider 10d —
IPO Mar 24, 1999
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 87.67
Forward P/E 31.85
PEG —
P/S 4.68
P/B 3.50
P/C —
EV/EBITDA 26.18
EV/Sales 4.75
Quick Ratio 2.66
Current Ratio 3.69
Debt/Eq 23.03
LT Debt/Eq —
EPS (ttm) 1.47
EPS next Y 4.05
EPS Growth 0.60%
Revenue Growth 8.50%
EPS Gr Q/Q 6.10%
Rev Gr Q/Q —
Earnings (next) 2026-05-11
Earnings (prior) 2026-02-23
ROA 4.54%
ROE 5.23%
ROIC —
Gross Margin 44.39%
Oper. Margin 11.66%
Profit Margin 5.49%
Shs Outstand 35.61M
Shs Float 35.37M
Insider Own 0.83%
Instit Own 116.16%
Short Float 15.11%
Short Ratio 11.66
Short Interest 4.03M
52W High 149.95
vs 52W High -14.05%
52W Low 98.27
vs 52W Low 31.15%
Beta 1.65
Impl. Vol. 62.65%
Rel Volume 0.68
Avg Volume 387.44K
Volume 263.83K
Target (mean) $157.00
Tgt Median $157.00
Tgt Low $144.00
Tgt High $170.00
# Analysts 2
Recom Strong_buy
Prev Close $132.78
Price $128.88
Change -2.94%
About

Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of-arm tooling, and bearing spindles. This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; imaging, identification and RFID solutions; advanced motion control solutions; and light engines, and integrated operating room technologies. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was incorporated in 1968 and is based in Bedford, Massachusetts.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$157.00
Mean price target
2. Current target
$128.88
Latest analyst target
3. DCF / Fair value
$32.49
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$128.88
Low
$144.00
High
$170.00
Mean
$157.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-30 up Baird Neutral → Outperform $144
2025-08-11 main Baird Neutral → Neutral $133
2025-03-03 main Baird Neutral → Neutral $160
2024-11-06 main Baird Neutral → Neutral $169
2024-08-07 main Baird Neutral → Neutral $175
2023-05-11 main Baird Neutral → Neutral $161
2022-05-11 up William Blair Market Perform → Outperform —
2020-11-13 init Berenberg — → Hold $109
2020-05-13 main Baird — → Neutral $90
2019-02-28 main Baird Neutral → Neutral $81
2018-05-09 down Baird Outperform → Neutral —
2018-02-27 init William Blair — → Outperform —
2017-12-08 init Baird — → Outperform $54
News
RSS: Latest NOVT news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-17 GLASTRA MATTHIJS Chief Executive Officer — 6,500 $130.05 $845,325
2026-03-16 BUCKLEY ROBERT J Chief Financial Officer — 9,957 $116.02 $1,162,651
2026-03-16 BUCKLEY ROBERT J Chief Financial Officer — 9,957 $14.13 $140,692
2026-03-02 GLASTRA MATTHIJS Chief Executive Officer — 6,500 $131.92 $899,239
2026-02-24 GLASTRA MATTHIJS Chief Executive Officer — 10,852 — —
2026-02-24 BURKE JOHN JOSEPH II Officer — 479 — —
2026-02-24 RAVETTO CHARLES GUY JR Chief Operating Officer — 825 — —
2026-02-24 BUCKLEY ROBERT J Chief Financial Officer — 5,426 — —
2026-02-23 BURKE JOHN JOSEPH II Officer — 519 — —
2026-02-23 RAVETTO CHARLES GUY JR Chief Operating Officer — 1,059 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
980.60
+3.30%
949.25
+7.67%
881.66
+2.41%
860.90
Operating Revenue
980.60
+3.30%
949.25
+7.67%
881.66
+2.41%
860.90
Cost Of Revenue
545.32
+3.34%
527.70
+9.53%
481.76
-0.14%
482.43
Reconciled Cost Of Revenue
510.86
+2.60%
497.93
+9.29%
455.60
0.00%
455.61
Gross Profit
435.28
+3.26%
421.55
+5.41%
399.90
+5.66%
378.47
Operating Expense
318.62
+7.19%
297.25
+7.47%
276.59
+2.06%
271.01
Research And Development
95.48
-0.03%
95.52
+4.18%
91.68
+6.89%
85.77
Selling General And Administration
195.66
+11.21%
175.94
+6.98%
164.46
+3.50%
158.90
Total Expenses
863.94
+4.73%
824.95
+8.78%
758.35
+0.65%
753.44
Operating Income
116.66
-6.14%
124.29
+0.80%
123.31
+14.75%
107.46
Total Operating Income As Reported
94.01
-14.99%
110.58
+0.08%
110.50
+7.20%
103.08
EBITDA
178.60
-0.70%
179.86
+5.85%
169.92
+5.79%
160.62
Normalized EBITDA
203.44
+5.33%
193.15
+5.55%
182.99
+10.95%
164.94
Reconciled Depreciation
61.93
+11.46%
55.56
+19.20%
46.61
-12.31%
53.16
EBIT
116.66
-6.14%
124.29
+0.80%
123.31
+14.75%
107.46
Total Unusual Items
-24.84
-86.84%
-13.30
-1.74%
-13.07
-202.73%
-4.32
Total Unusual Items Excluding Goodwill
-24.84
-86.84%
-13.30
-1.74%
-13.07
-202.73%
-4.32
Special Income Charges
-22.65
-65.23%
-13.71
-6.98%
-12.81
-192.29%
-4.38
Restructuring And Mergern Acquisition
22.65
+65.23%
13.71
+6.98%
12.81
+192.29%
4.38
Net Income
53.83
-16.01%
64.09
-12.06%
72.88
-1.58%
74.05
Pretax Income
69.64
-11.92%
79.07
-5.59%
83.75
-3.91%
87.16
Net Non Operating Interest Income Expense
-21.47
+31.81%
-31.49
-21.97%
-25.82
-65.33%
-15.62
Net Interest Income
-21.47
+31.81%
-31.49
-21.97%
-25.82
-65.33%
-15.62
Other Income Expense
-25.55
-85.98%
-13.74
+0.04%
-13.74
-193.17%
-4.69
Other Non Operating Income Expenses
-0.71
-60.18%
-0.44
+34.52%
-0.68
-81.94%
-0.37
Gain On Sale Of Security
-2.19
-630.27%
0.41
+261.96%
-0.26
-480.60%
0.07
Tax Provision
15.81
+5.57%
14.98
+37.80%
10.87
-17.07%
13.11
Tax Rate For Calcs
0.00
+19.85%
0.00
+45.73%
0.00
-13.33%
0.00
Tax Effect Of Unusual Items
-5.64
-123.93%
-2.52
-48.26%
-1.70
-162.37%
-0.65
Net Income Including Noncontrolling Interests
53.83
-16.01%
64.09
-12.06%
72.88
-1.58%
74.05
Net Income From Continuing Operation Net Minority Interest
53.83
-16.01%
64.09
-12.06%
72.88
-1.58%
74.05
Net Income From Continuing And Discontinued Operation
53.83
-16.01%
64.09
-12.06%
72.88
-1.58%
74.05
Net Income Continuous Operations
53.83
-16.01%
64.09
-12.06%
72.88
-1.58%
74.05
Normalized Income
73.03
-2.45%
74.86
-11.14%
84.25
+8.40%
77.72
Net Income Common Stockholders
53.83
-16.01%
64.09
-12.06%
72.88
-1.58%
74.05
Diluted EPS
1.47
-16.95%
1.77
-12.38%
2.02
-1.94%
2.06
Basic EPS
1.47
-17.42%
1.78
-12.32%
2.03
-2.40%
2.08
Basic Average Shares
36.59
+1.78%
35.95
+0.30%
35.84
+0.54%
35.65
Diluted Average Shares
36.70
+1.60%
36.12
+0.26%
36.03
+0.34%
35.91
Diluted NI Availto Com Stockholders
53.83
-16.01%
64.09
-12.06%
72.88
-1.58%
74.05
Amortization
27.48
+6.52%
25.79
+26.16%
20.45
-22.37%
26.34
Amortization Of Intangibles Income Statement
27.48
+6.52%
25.79
+26.16%
20.45
-22.37%
26.34
Depreciation Amortization Depletion Income Statement
27.48
+6.52%
25.79
+26.16%
20.45
-22.37%
26.34
Depreciation And Amortization In Income Statement
27.48
+6.52%
25.79
+26.16%
20.45
-22.37%
26.34
Total Other Finance Cost
21.47
-31.81%
31.49
+21.97%
25.82
+65.33%
15.62
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
1,807.11
+30.15%
1,388.51
+13.25%
1,226.06
-1.22%
1,241.21
Current Assets
782.60
+80.47%
433.65
+4.42%
415.30
-1.24%
420.52
Cash Cash Equivalents And Short Term Investments
380.87
+234.13%
113.99
+8.51%
105.05
+4.94%
100.11
Cash And Cash Equivalents
380.87
+234.13%
113.99
+8.51%
105.05
+4.94%
100.11
Receivables
194.26
+22.10%
159.10
+7.85%
147.51
+5.97%
139.21
Accounts Receivable
184.88
+22.42%
151.03
+8.33%
139.41
+1.24%
137.70
Gross Accounts Receivable
186.22
+22.89%
151.53
+8.25%
139.98
+0.93%
138.69
Allowance For Doubtful Accounts Receivable
-1.34
-165.54%
-0.51
+11.56%
-0.57
+42.61%
-0.99
Taxes Receivable
9.38
+16.17%
8.08
-0.36%
8.11
+437.47%
1.51
Inventory
188.28
+30.20%
144.61
-3.19%
149.37
-11.09%
168.00
Raw Materials
123.31
+33.74%
92.20
-11.89%
104.64
-11.54%
118.29
Work In Process
32.48
+31.39%
24.72
+17.65%
21.01
-9.94%
23.33
Finished Goods
31.72
+16.06%
27.33
+17.23%
23.31
-9.43%
25.74
Prepaid Assets
—
—
—
—
Other Current Assets
19.18
+20.27%
15.95
+19.39%
13.36
+1.12%
13.21
Total Non Current Assets
1,024.51
+7.29%
954.86
+17.77%
810.76
-1.21%
820.69
Net PPE
160.19
+2.66%
156.04
+5.61%
147.75
+0.85%
146.50
Gross PPE
292.75
+9.31%
267.82
+6.78%
250.81
+4.70%
239.56
Accumulated Depreciation
-132.56
-18.59%
-111.78
-8.46%
-103.06
-10.75%
-93.05
Properties
103.86
+4.68%
99.22
+4.42%
95.02
+10.45%
86.03
Machinery Furniture Equipment
147.19
+17.11%
125.69
+6.99%
117.49
+6.60%
110.21
Other Properties
41.70
-2.82%
42.91
+12.03%
38.30
-11.58%
43.32
Goodwill And Other Intangible Assets
828.12
+7.56%
769.94
+22.30%
629.53
-3.84%
654.66
Goodwill
647.35
+10.83%
584.10
+20.56%
484.51
+1.17%
478.90
Other Intangible Assets
180.78
-2.73%
185.84
+28.15%
145.02
-17.49%
175.77
Non Current Deferred Assets
27.38
+19.64%
22.89
-17.86%
27.86
+84.36%
15.11
Non Current Deferred Taxes Assets
27.38
+19.64%
22.89
-17.86%
27.86
+84.36%
15.11
Other Non Current Assets
8.81
+47.09%
5.99
+6.66%
5.62
+27.25%
4.41
Total Liabilities Net Minority Interest
492.82
-23.33%
642.81
+16.33%
552.60
-16.73%
663.63
Current Liabilities
212.37
+26.57%
167.79
+20.56%
139.18
-15.41%
164.52
Payables And Accrued Expenses
119.90
+15.42%
103.88
+47.87%
70.25
-25.27%
94.01
Payables
100.72
+8.43%
92.89
+42.99%
64.96
-26.91%
88.89
Accounts Payable
94.86
+23.38%
76.89
+34.43%
57.20
-23.97%
75.22
Current Accrued Expenses
19.18
+74.47%
10.99
+107.73%
5.29
+3.22%
5.13
Employee Benefits
—
—
—
—
Pensionand Other Post Retirement Benefit Plans Current
16.41
-42.16%
28.36
-13.28%
32.70
-7.88%
35.50
Total Tax Payable
5.86
-63.40%
16.00
+106.00%
7.77
-43.14%
13.66
Income Tax Payable
5.86
-63.40%
16.00
+106.00%
7.77
-43.14%
13.66
Current Debt And Capital Lease Obligation
48.15
+230.46%
14.57
+5.01%
13.88
+4.63%
13.26
Current Debt
38.29
+716.27%
4.69
-5.58%
4.97
+3.50%
4.80
Other Current Borrowings
38.29
+716.27%
4.69
-5.58%
4.97
+3.50%
4.80
Current Capital Lease Obligation
9.86
-0.22%
9.88
+10.91%
8.91
+5.27%
8.46
Current Deferred Liabilities
10.95
+91.51%
5.71
+2.92%
5.55
-31.68%
8.13
Current Deferred Revenue
10.95
+91.51%
5.71
+2.92%
5.55
-31.68%
8.13
Other Current Liabilities
16.97
+11.18%
15.26
-9.10%
16.79
+23.27%
13.62
Total Non Current Liabilities Net Minority Interest
280.45
-40.96%
475.02
+14.90%
413.42
-17.17%
499.10
Long Term Debt And Capital Lease Obligation
253.76
-44.31%
455.67
+16.63%
390.68
-17.94%
476.12
Long Term Debt
212.54
-48.41%
411.95
+17.90%
349.40
-18.87%
430.66
Long Term Capital Lease Obligation
41.22
-5.72%
43.72
+5.92%
41.28
-9.20%
45.46
Non Current Pension And Other Postretirement Benefit Plans
—
—
—
—
Tradeand Other Payables Non Current
3.96
-19.79%
4.94
+11.41%
4.43
+1.84%
4.36
Non Current Deferred Liabilities
18.09
+38.18%
13.09
-19.70%
16.30
-5.17%
17.19
Non Current Deferred Taxes Liabilities
18.09
+38.18%
13.09
-19.70%
16.30
-5.17%
17.19
Other Non Current Liabilities
4.64
+252.43%
1.32
-21.99%
1.69
+49.03%
1.13
Stockholders Equity
1,314.29
+76.25%
745.70
+10.73%
673.46
+16.60%
577.59
Common Stock Equity
1,314.29
+76.25%
745.70
+10.73%
673.46
+16.60%
577.59
Capital Stock
423.86
+0.00%
423.86
+0.00%
423.86
+0.00%
423.86
Common Stock
423.86
+0.00%
423.86
+0.00%
423.86
+0.00%
423.86
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
35.67
-0.74%
35.94
+0.35%
35.81
+0.29%
35.71
Ordinary Shares Number
35.67
-0.74%
35.94
+0.35%
35.81
+0.29%
35.71
Additional Paid In Capital
572.06
+579.29%
84.21
+20.00%
70.18
+27.24%
55.16
Retained Earnings
321.38
+20.12%
267.55
+31.50%
203.46
+55.81%
130.58
Gains Losses Not Affecting Retained Earnings
-3.00
+89.96%
-29.92
-24.47%
-24.04
+24.90%
-32.01
Other Equity Adjustments
-3.00
+89.96%
-29.92
-24.47%
-24.04
+24.90%
-32.01
Total Equity Gross Minority Interest
1,314.29
+76.25%
745.70
+10.73%
673.46
+16.60%
577.59
Total Capitalization
1,526.83
+31.89%
1,157.65
+13.18%
1,022.86
+1.45%
1,008.25
Working Capital
570.23
+114.49%
265.86
-3.72%
276.12
+7.86%
256.00
Invested Capital
1,565.12
+34.65%
1,162.34
+13.09%
1,027.83
+1.46%
1,013.05
Total Debt
301.91
-35.80%
470.24
+16.24%
404.56
-17.33%
489.38
Net Debt
—
302.65
+21.39%
249.32
-25.66%
335.36
Capital Lease Obligations
51.08
-4.71%
53.60
+6.81%
50.19
-6.93%
53.92
Net Tangible Assets
486.16
+2105.29%
-24.24
-155.19%
43.93
+157.00%
-77.08
Tangible Book Value
486.16
+2105.29%
-24.24
-155.19%
43.93
+157.00%
-77.08
Non Current Accrued Expenses
—
0.00
-100.00%
0.31
+3.32%
0.30
Other Inventories
0.78
+116.57%
0.36
-11.06%
0.41
-36.31%
0.64
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
64.06
-59.59%
158.51
+32.01%
120.08
+32.27%
90.78
Cash Flow From Continuing Operating Activities
64.06
-59.59%
158.51
+32.01%
120.08
+32.27%
90.78
Net Income From Continuing Operations
53.83
-16.01%
64.09
-12.06%
72.88
-1.58%
74.05
Depreciation Amortization Depletion
61.93
+11.46%
55.56
+19.20%
46.61
-12.31%
53.16
Depreciation
18.18
+21.23%
15.00
+6.98%
14.02
+3.45%
13.55
Amortization Cash Flow
43.75
+7.85%
40.57
+24.46%
32.59
-17.71%
39.61
Depreciation And Amortization
61.93
+11.46%
55.56
+19.20%
46.61
-12.31%
53.16
Amortization Of Intangibles
43.75
+7.85%
40.57
+24.46%
32.59
-17.71%
39.61
Other Non Cash Items
3.58
-6.32%
3.83
+145.48%
1.56
+68.36%
0.93
Stock Based Compensation
29.54
+26.73%
23.31
-8.91%
25.59
+10.73%
23.11
Provisionand Write Offof Assets
3.27
-62.83%
8.78
+17.25%
7.49
+150.70%
2.99
Asset Impairment Charge
0.00
0.00
-100.00%
1.85
0.00
Deferred Tax
-8.85
+44.35%
-15.91
-8.03%
-14.73
+21.06%
-18.65
Deferred Income Tax
-8.85
+44.35%
-15.91
-8.03%
-14.73
+21.06%
-18.65
Operating Gains Losses
-4.11
-6317.19%
-0.06
-143.24%
0.15
+342.62%
-0.06
Gain Loss On Sale Of PPE
-4.11
-6317.19%
-0.06
-143.24%
0.15
+342.62%
-0.06
Change In Working Capital
-75.13
-497.15%
18.92
+188.70%
-21.33
+52.33%
-44.74
Change In Receivables
-27.27
-340.37%
-6.19
-4776.38%
-0.13
+99.45%
-23.25
Changes In Account Receivables
-27.27
-340.37%
-6.19
-4776.38%
-0.13
+99.45%
-23.25
Change In Inventory
-36.10
-855.09%
4.78
-57.94%
11.37
+123.41%
-48.55
Change In Prepaid Assets
-1.27
+14.95%
-1.49
-310.44%
0.71
+187.10%
-0.81
Change In Payables And Accrued Expense
3.71
-71.62%
13.06
+163.86%
-20.45
-167.43%
30.33
Change In Payable
3.71
-71.62%
13.06
+163.86%
-20.45
-167.43%
30.33
Change In Account Payable
3.71
-71.62%
13.06
+163.86%
-20.45
-167.43%
30.33
Change In Other Working Capital
-14.20
-262.08%
8.76
+168.31%
-12.82
-420.63%
-2.46
Investing Cash Flow
-74.32
+64.30%
-208.19
-946.60%
-19.89
+53.24%
-42.54
Cash Flow From Continuing Investing Activities
-74.32
+64.30%
-208.19
-946.60%
-19.89
+53.24%
-42.54
Net PPE Purchase And Sale
-10.03
+40.96%
-16.99
+14.59%
-19.89
+5.17%
-20.98
Purchase Of PPE
-15.63
+8.94%
-17.16
+14.02%
-19.96
+5.46%
-21.11
Sale Of PPE
5.60
+3134.68%
0.17
+150.72%
0.07
-49.64%
0.14
Capital Expenditure
-15.63
+8.94%
-17.16
+14.02%
-19.96
+5.46%
-21.11
Net Business Purchase And Sale
-64.29
+66.38%
-191.20
0.00
+100.00%
-21.57
Purchase Of Business
-64.29
+66.38%
-191.20
0.00
+100.00%
-21.57
Net Intangibles Purchase And Sale
—
—
—
-1.47
Purchase Of Intangibles
—
—
—
-1.47
Financing Cash Flow
276.33
+385.27%
56.94
+158.19%
-97.85
-62.67%
-60.15
Cash Flow From Continuing Financing Activities
276.33
+385.27%
56.94
+158.19%
-97.85
-62.67%
-60.15
Net Issuance Payments Of Debt
-282.92
-522.69%
66.93
+177.33%
-86.55
-893.18%
10.91
Issuance Of Debt
82.81
-58.18%
198.00
0.00
-100.00%
69.94
Repayment Of Debt
-365.73
-179.04%
-131.07
-51.43%
-86.55
-46.63%
-59.03
Long Term Debt Payments
—
—
0.00
0.00
Net Long Term Debt Issuance
—
—
0.00
0.00
Short Term Debt Issuance
82.81
-58.18%
198.00
0.00
-100.00%
69.94
Short Term Debt Payments
-365.73
-179.04%
-131.07
-51.43%
-86.55
-46.63%
-59.03
Net Short Term Debt Issuance
-282.92
-522.69%
66.93
+177.33%
-86.55
-893.18%
10.91
Net Common Stock Issuance
575.11
0.00
0.00
+100.00%
-10.00
Common Stock Payments
-39.28
0.00
0.00
+100.00%
-10.00
Repurchase Of Capital Stock
-39.28
0.00
0.00
+100.00%
-10.00
Net Other Financing Charges
-15.86
-58.76%
-9.99
+11.59%
-11.30
+81.49%
-61.07
Changes In Cash
266.06
+3561.77%
7.27
+211.85%
2.33
+119.55%
-11.92
Beginning Cash Position
113.99
+8.51%
105.05
+4.94%
100.11
-14.73%
117.39
End Cash Position
380.87
+234.13%
113.99
+8.51%
105.05
+4.94%
100.11
Free Cash Flow
48.43
-65.74%
141.35
+41.19%
100.11
+43.71%
69.67
Interest Paid Supplemental Data
22.57
-30.93%
32.67
+29.13%
25.30
+77.38%
14.26
Income Tax Paid Supplemental Data
38.67
+82.81%
21.15
-42.68%
36.90
+81.87%
20.29
Common Stock Issuance
614.39
0.00
0.00
—
Issuance Of Capital Stock
614.39
0.00
0.00
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category